Eukaryotic Elongation Factor 1A Interacts with Sphingosine Kinase and Directly Enhances Its Catalytic Activity

Por Leclercq, Tamara M., Moretti, Paul A. B., Vadas, Mathew A., Pitson, Stuart M.
Publicado em 2008

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia

Por Banjar, Haneen, Ranasinghe, Damith, Brown, Fred, Adelson, David, Kroger, Trent, Leclercq, Tamara, White, Deborah, Hughes, Timothy, Chaudhri, Naeem
Publicado no PLoS One (2017)

Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling

Por Pitson, Stuart M., Xia, Pu, Leclercq, Tamara M., Moretti, Paul A.B., Zebol, Julia R., Lynn, Helen E., Wattenberg, Binks W., Vadas, Mathew A.
Publicado em 2005

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells

Por Wang, Jueqiong, Lu, Liu, Kok, Chung H., Saunders, Verity A., Goyne, Jarrad M., Dang, Phuong, Leclercq, Tamara M., Hughes, Timothy P., White, Deborah L.
Publicado no Haematologica (2017)

The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells

Por Loveridge, Carolyn, Tonelli, Francesca, Leclercq, Tamara, Lim, Keng Gat, Long, Jaclyn S., Berdyshev, Evgeny, Tate, Rothwelle J., Natarajan, Viswanathan, Pitson, Stuart M., Pyne, Nigel J., Pyne, Susan
Publicado em 2010

An oncogenic role for sphingosine kinase 2

Por Neubauer, Heidi A., Pham, Duyen H., Zebol, Julia R., Moretti, Paul A.B., Peterson, Amanda L., Leclercq, Tamara M., Chan, Huasheng, Powell, Jason A., Pitman, Melissa R., Samuel, Michael S., Bonder, Claudine S., Creek, Darren J., Gliddon, Briony L., Pitson, Stuart M.
Publicado no Oncotarget (2016)